Adults with suspected or confirmed acute COVID-19 infection (fever and at least one symptom of respiratory disease requiring hospitalisation) who are ≥40 years old are potentially eligible to participate in the CRASH-19 trial.
Eligible patients will be randomised to one of eight arms: aspirin only; losartan only; simvastatin only; aspirin and losartan; aspirin and simvastatin; losartan and simvastatin; aspirin, losartan and simvastatin; standard care only
The trial design is pragmatic and efficient to allow rapid recruitment while minimising the burden on front-line health workers.
Please click on the icons below to access the trial training and materials:
